Oncimmune Begin Period Cash Flow from 2010 to 2025

ONC Stock   2.72  0.24  9.68%   
Oncimmune Holdings' Begin Period Cash Flow is increasing over the years with stable fluctuation. Overall, Begin Period Cash Flow is expected to go to about 5.1 M this year. Begin Period Cash Flow is the amount of cash Oncimmune Holdings plc has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2013-01-31
Previous Quarter
780 K
Current Value
3.2 M
Quarterly Volatility
2.1 M
 
Yuan Drop
 
Covid
Check Oncimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncimmune Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 324.7 K, Interest Expense of 656.3 K or Selling General Administrative of 1.9 M, as well as many indicators such as . Oncimmune financial statements analysis is a perfect complement when working with Oncimmune Holdings Valuation or Volatility modules.
  
This module can also supplement various Oncimmune Holdings Technical models . Check out the analysis of Oncimmune Holdings Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.